Literature DB >> 33488595

Current Understanding of Leukocyte Phenotypic and Functional Modulation During Extracorporeal Membrane Oxygenation: A Narrative Review.

Katrina K Ki1,2, Jonathan E Millar1,2,3, Daman Langguth4, Margaret R Passmore1,2, Charles I McDonald1,5, Kiran Shekar1,6, Manu Shankar-Hari7,8, Hwa Jin Cho1,2,9, Jacky Y Suen1,2, John F Fraser1,2.   

Abstract

A plethora of leukocyte modulations have been reported in critically ill patients. Critical illnesses such as acute respiratory distress syndrome and cardiogenic shock, which potentially require extracorporeal membrane oxygenation (ECMO) support, are associated with changes in leukocyte numbers, phenotype, and functions. The changes observed in these illnesses could be compounded by exposure of blood to the non-endothelialized surfaces and non-physiological conditions of ECMO. This can result in further leukocyte activation, increased platelet-leukocyte interplay, pro-inflammatory and pro-coagulant state, alongside features of immunosuppression. However, the effects of ECMO on leukocytes, in particular their phenotypic and functional signatures, remain largely overlooked, including whether these changes have attributable mortality and morbidity. The aim of our narrative review is to highlight the importance of studying leukocyte signatures to better understand the development of complications associated with ECMO. Increased knowledge and appreciation of their probable role in ECMO-related adverse events may assist in guiding the design and establishment of targeted preventative actions.
Copyright © 2021 Ki, Millar, Langguth, Passmore, McDonald, Shekar, Shankar-Hari, Cho, Suen and Fraser.

Entities:  

Keywords:  critically ill patients; extracorporeal membrane oxygenation; extracorporeal membrane oxygenation technology; innate and adaptive immunity; leukocyte modulation

Mesh:

Year:  2021        PMID: 33488595      PMCID: PMC7821656          DOI: 10.3389/fimmu.2020.600684

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  111 in total

1.  Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment.

Authors:  U Sester; M Sester; G Heine; H Kaul; M Girndt; H Köhler
Journal:  Nephrol Dial Transplant       Date:  2001-07       Impact factor: 5.992

2.  Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer.

Authors:  Roy S Herbst; S Gail Eckhardt; Razelle Kurzrock; Scot Ebbinghaus; Peter J O'Dwyer; Michael S Gordon; William Novotny; Meredith A Goldwasser; Tanyifor M Tohnya; Bert L Lum; Avi Ashkenazi; Adrian M Jubb; David S Mendelson
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

3.  Flow dynamics of different adult ECMO systems: a clinical evaluation.

Authors:  Karla Lehle; Alois Philipp; Thomas Müller; Frank Schettler; Thomas Bein; Christof Schmid; Matthias Lubnow
Journal:  Artif Organs       Date:  2013-10-01       Impact factor: 3.094

4.  Inflammation and lung injury in an ovine model of extracorporeal membrane oxygenation support.

Authors:  Margaret R Passmore; Yoke L Fung; Gabriela Simonova; Samuel R Foley; Kimble R Dunster; Sara D Diab; John-Paul Tung; Robyn M Minchinton; Charles I McDonald; Chris M Anstey; Kiran Shekar; John F Fraser
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-11-04       Impact factor: 5.464

5.  Importance of monocyte deactivation in determining early outcome after ventricular assist device implantation.

Authors:  Matthias Kirsch; Bernadette Boval; Thibaud Damy; Soulef Ghendouz; Emmanuelle Vermes; Daniel Loisance; Ludovic Drouet
Journal:  Int J Artif Organs       Date:  2012-03       Impact factor: 1.595

6.  Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome.

Authors:  Mark W Hall; Nina L Knatz; Carol Vetterly; Steven Tomarello; Mark D Wewers; Hans Dieter Volk; Joseph A Carcillo
Journal:  Intensive Care Med       Date:  2010-12-10       Impact factor: 17.440

7.  Effects of simulated extracorporeal circulation on human leukocyte elastase release, superoxide generation, and procoagulant activity.

Authors:  R F Stahl; C A Fisher; U Kucich; G Weinbaum; D S Warsaw; N Stenach; C O'Connor; V P Addonizio
Journal:  J Thorac Cardiovasc Surg       Date:  1991-02       Impact factor: 5.209

8.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.

Authors:  Giles J Peek; Miranda Mugford; Ravindranath Tiruvoipati; Andrew Wilson; Elizabeth Allen; Mariamma M Thalanany; Clare L Hibbert; Ann Truesdale; Felicity Clemens; Nicola Cooper; Richard K Firmin; Diana Elbourne
Journal:  Lancet       Date:  2009-09-15       Impact factor: 79.321

9.  Inhibition of neutrophil activity improves cardiac function after cardiopulmonary bypass.

Authors:  Ulf Abdel-Rahman; Stefan Margraf; Tayfun Aybek; Tim Lögters; José Bitu-Moreno; Ieda Francischetti; Tilmann Kranert; Frank Grünwald; Joachim Windolf; Anton Moritz; Martin Scholz
Journal:  J Inflamm (Lond)       Date:  2007-10-10       Impact factor: 4.981

10.  A Pilot Study Identifying Brain-Targeting Adaptive Immunity in Pediatric Extracorporeal Membrane Oxygenation Patients With Acquired Brain Injury.

Authors:  Sterling B Ortega; Poornima Pandiyan; Jana Windsor; Vanessa O Torres; Uma M Selvaraj; Amy Lee; Michael Morriss; Fenghua Tian; Lakshmi Raman; Ann M Stowe
Journal:  Crit Care Med       Date:  2019-03       Impact factor: 7.598

View more
  2 in total

1.  Monocyte Dysfunction Detected by the Designed Ankyrin Repeat Protein F7 Predicts Mortality in Patients Receiving Veno-Arterial Extracorporeal Membrane Oxygenation.

Authors:  Patrick M Siegel; Lukas Orlean; István Bojti; Klaus Kaier; Thilo Witsch; Jennifer S Esser; Georg Trummer; Martin Moser; Karlheinz Peter; Christoph Bode; Philipp Diehl
Journal:  Front Cardiovasc Med       Date:  2021-07-19

2.  Thrombus formation during ECMO: Insights from a detailed histological analysis of thrombus composition.

Authors:  Senna Staessens; Mouhamed D Moussa; Adeline Pierache; Antoine Rauch; Natacha Rousse; Eric Boulleaux; Alexandre Ung; Linda Desender; Bénédicte Pradines; André Vincentelli; Olaf Mercier; Julien Labreuche; Alain Duhamel; Eric Van Belle; Flavien Vincent; Annabelle Dupont; Karen Vanhoorelbeke; Delphine Corseaux; Simon F De Meyer; Sophie Susen
Journal:  J Thromb Haemost       Date:  2022-07-03       Impact factor: 16.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.